245 related articles for article (PubMed ID: 33714203)
1. Comprehensive analysis of expression and prognostic value of the claudin family in human breast cancer.
Yang G; Jian L; Chen Q
Aging (Albany NY); 2021 Mar; 13(6):8777-8796. PubMed ID: 33714203
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
Front Genet; 2022; 13():783016. PubMed ID: 35281827
[No Abstract] [Full Text] [Related]
3. Claudin expression in breast cancer: high or low, what to expect?
Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Claudin 12 in estrogen receptor-negative breast cancer.
Iravani O; Yip GW; Thike AA; Chua PJ; Jane Scully O; Tan PH; Bay BH
J Clin Pathol; 2016 Oct; 69(10):878-83. PubMed ID: 26926102
[TBL] [Abstract][Full Text] [Related]
5. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
Uthayanan L; El-Bahrawy M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
[TBL] [Abstract][Full Text] [Related]
6. [Claudins as prognostic factors of breast cancer].
Szász MA
Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
[TBL] [Abstract][Full Text] [Related]
7. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
Zhou S; Piao X; Wang C; Wang R; Song Z
Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
[TBL] [Abstract][Full Text] [Related]
8. Identification of claudin-2, -6, -11 and -14 as prognostic markers in human breast carcinoma.
Jia H; Chai X; Li S; Wu D; Fan Z
Int J Clin Exp Pathol; 2019; 12(6):2195-2204. PubMed ID: 31934042
[TBL] [Abstract][Full Text] [Related]
9. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas.
Nordfors K; Haapasalo J; Sallinen PK; Haapasalo H; Soini Y
Histol Histopathol; 2013 Sep; 28(9):1137-46. PubMed ID: 23423606
[TBL] [Abstract][Full Text] [Related]
10. Claudins and hepatocellular carcinoma.
Wang W; Zhou Y; Li W; Quan C; Li Y
Biomed Pharmacother; 2024 Feb; 171():116109. PubMed ID: 38185042
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic and prognosis features of Claudin-low breast cancers].
Xu J; Lan KT; Su TH; Li ZF; Wan Y; Gu QQ; Zou PC; Zou X
Zhonghua Bing Li Xue Za Zhi; 2017 Sep; 46(9):634-639. PubMed ID: 28910875
[No Abstract] [Full Text] [Related]
12. Claudins as diagnostic and prognostic markers in gynecological cancer.
Szabó I; Kiss A; Schaff Z; Sobel G
Histol Histopathol; 2009 Dec; 24(12):1607-15. PubMed ID: 19795358
[TBL] [Abstract][Full Text] [Related]
13. Claudin-3, claudin-7, and claudin-10 show different distribution patterns during decidualization and trophoblast invasion in mouse and human.
Schumann S; Buck VU; Classen-Linke I; Wennemuth G; Grümmer R
Histochem Cell Biol; 2015 Dec; 144(6):571-85. PubMed ID: 26340953
[TBL] [Abstract][Full Text] [Related]
14. [Study of claudins and prognostic factors in some gastrointestinal diseases].
Gyorffy H
Magy Onkol; 2009 Dec; 53(4):377-83. PubMed ID: 20071310
[TBL] [Abstract][Full Text] [Related]
15. Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder.
Székely E; Törzsök P; Riesz P; Korompay A; Fintha A; Székely T; Lotz G; Nyirády P; Romics I; Tímár J; Schaff Z; Kiss A
J Histochem Cytochem; 2011 Oct; 59(10):932-41. PubMed ID: 21832144
[TBL] [Abstract][Full Text] [Related]
16. Claudin reduction may relate to an impaired skin barrier in rosacea.
Deng Z; Chen M; Xie H; Jian D; Xu S; Peng Q; Sha K; Liu Y; Zhang Y; Shi W; Li J
J Dermatol; 2019 Apr; 46(4):314-321. PubMed ID: 30714633
[TBL] [Abstract][Full Text] [Related]
17. Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
Wahdan-Alaswad R; Harrell JC; Fan Z; Edgerton SM; Liu B; Thor AD
Cell Cycle; 2016; 15(8):1046-59. PubMed ID: 26919310
[TBL] [Abstract][Full Text] [Related]
18. High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer.
Jääskeläinen A; Soini Y; Jukkola-Vuorinen A; Auvinen P; Haapasaari KM; Karihtala P
BMC Cancer; 2018 Feb; 18(1):223. PubMed ID: 29482498
[TBL] [Abstract][Full Text] [Related]
19. The claudin gene family: expression in normal and neoplastic tissues.
Hewitt KJ; Agarwal R; Morin PJ
BMC Cancer; 2006 Jul; 6():186. PubMed ID: 16836752
[TBL] [Abstract][Full Text] [Related]
20. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
